Major drugmakers’ 1H profits slashed by cuts in drug prices

Published: 2012-08-09 07:00:00

Updated: 2012-08-09 07:00:00

After the government forced down prices of medicines in April, the country’s leading pharmaceutical companies including top-tier ones have struggled to keep afloat in the first half of the year.

Despite increased sales by 6.9 percent on-year, market leaders like Dong-A Pharmaceutical, Daewoong...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK